Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Standby Equity Purchase Agreement [Member]
Statistical Measurement [Axis]
Maximum [Member]
Securities Purchase Agreement [Member]
Legal Entity [Axis]
Pharm Ala Biotech Holdings Inc. [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Antidilutive Securities [Axis]
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Option [Member]
Titan Advisory Services LLC [Member]
Employment Agreements [Member]
YA II PN, Ltd [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche Two [Member]
Debt Instrument [Axis]
Convertible Promissory Note [Member]
Convertible Promissory Note One [Member]
2025 Convertible Notes [Member]
SEPA [Member]
Convertible Note One [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Valuation Approach and Technique [Axis]
Valuation Technique, Monte Carlo Pricing Model [Member]
Measurement Input, Option Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Minimum [Member]
Financial Instrument [Axis]
Notes [Member]
Plan Name [Axis]
2025 Equity Incentive Plan [Member]
Sale of Stock [Axis]
IPO [Member]
Entity Three [Member]
Title and Position [Axis]
Two Consultants [Member]
Office Employees [Member]
Director [Member]
Exercise Price Range [Axis]
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Range Seven [Member]
Range Eight [Member]
Range Nine [Member]
Range Ten [Member]
Consulting Agreements [Member]
Consulting Agreement [Member]
License Agreements [Member]
Aquanova AG [Member]
Licensing and Royalty Agreements [Member]
Debt Forgiveness and Exchange Agreement [Member]
Segments [Axis]
Pharmaceutical Operations [Member]
Consolidation Items [Axis]
Reportable Geographical Components [Member]
Premium Nutritional Supplements [Member]
Corporate Segment and Other Operating Segment [Member]
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
License Agreement [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
Assets
Current Assets:
Cash
Accounts receivable
Prepaid contracts
Inventory, net
Other current assets
Total current assets
Operating lease right of use asset, net
Prepaid contracts, noncurrent
Other assets
Total assets
Liabilities and Stockholders’ Deficit
Current Liabilities:
Accounts payable and accrued expenses
Accrued compensation
Accrued interest
Deferred revenue
Operating lease liability
Convertible notes payable, fair value
Refund liability
Total current liabilities
Operating lease liability, net of current portion
Total liabilities
Commitments and Contingencies (Note 7)
Stockholders’ Deficit:
Series A preferred stock, par value $0.0001; 5,000,000 shares authorized, nil shares issued and outstanding
Common stock, par value $0.0001; 500,000,000 and 125,000,000 shares authorized, respectively; 664,670 and 459,286 issued and outstanding, respectively
Additional paid in capital
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit
Series A preferred stock, par value
Series A preferred stock, shares authorized
Series A preferred stock, shares issued
Series A preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, share issued
Common stock, share outstanding
Income Statement [Abstract]
Product revenues, net
Cost of goods sold
Gross Profit
Expenses:
Research and development
General and administrative
Total operating expenses
Operating loss
Other income (expenses):
Interest income
Gain on change in fair value of convertible notes
Interest expense
Total other income (expenses), net
Net loss
Net loss per common share:
Weighted average number of common shares outstanding:
Net loss per common share: Basic
Net loss per common share: Diluted
Weighted average number of common shares outstanding: Basic
Weighted average number of common shares outstanding: Diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Stock-based compensation
Shares issued for exercise of stock options
Shares issued for exercise of stock options, shares
Issuance of common stock for payment of notes and interest
Issuance of common stock for payment of notes and interest, shares
Shares issued for conversion of convertible notes
Shares issued for conversion of convertible notes, shares
Shares issued for services rendered
Shares issued for services rendered, shares
Reverse stock split rounding adjustment
Reverse stock split rounding adjustment, shares
Net operating loss
Registered direct offering, net of offering costs
Registered direct offering, net of offering costs, shares
Shares issued for vested restricted stock units
Shares issued for vested restricted stock units, shares
Reverse stock split rounding adjustment, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash Flows from Operating Activities:
Net Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on change in fair value of convertible notes
Interest expense paid through sale of common stock
Amortization of prepaid contracts
Stock-based compensation
Shares issued for services
Change in operating lease right of use asset and lease liabilities
Decreases (increases) in operating assets and liabilities:
Accounts receivable
Prepaid contracts
PharmAla escrow deposit -other assets
Inventory
Other assets
Accounts payable and accrued expenses
Accrued compensation
Deferred revenue
Refund liability
Accrued interest
Net cash used in operating activities
Cash Flows from Financing Activities:
Proceeds from exercise of stock options
Payment on convertible note payable
Proceeds from offering, net of costs
Net cash provided by financing activities
Net Change in Cash
Beginning of period
End of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Operating lease right-of-use asset obtained in exchange for operating lease liability
Schedule of Non-Cash Investing and Financing Activities:
Payment of convertible note from issuance of common stock
Stock issued in connection with interest payment
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Type [Axis]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Rule 10b5-1 Arrangement Modified
Non-Rule 10b5-1 Arrangement Modified
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business
Accounting Policies [Abstract]
Significant Accounting Policies
Related Party Transactions [Abstract]
Related Party Transactions
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses
Debt Disclosure [Abstract]
Standby Equity Purchase Agreement and Convertible Debt
Equity [Abstract]
Stockholders’ Equity (Deficit)
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Segment Reporting [Abstract]
Segment Report
Subsequent Events [Abstract]
Subsequent Events
Basis of presentation, Liquidity and Management’s Plans
Business Segment
Use of Estimates
Cash
Inventory
Revenue Recognition
Prepaid Contracts
Other Assets
Research and Development
Income Taxes
Loss Per Share of Common Stock
Stock-Based Compensation
Clinical Trial Expenses
Fair Value of Financial Instruments and Fair Value Measurements
Convertible Notes with Embedded Derivative Liabilities
Leases
Schedule of Accounts Payable and Accrued Expenses
Schedule of Fair Value Asset Measuring Non-recurring Basis
Schedule of Summary of Activity and Fair Value Measurement
Schedule of Grant Date Fair Value of Stock Options Issued
Schedule of Stock Option Activity
Schedule of Employee Stock Options Outstanding
Schedule of Operating Lease Right-of-use Asset and Liability
Schedule of Future Minimum Lease Liability Payments Under Non-cancelable Operating Lease
Schedule of Segment Information
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of Stock, Consideration Received on Transaction
Sale of Stock, Number of Shares Issued in Transaction
Sale of Stock, Price Per Share
Placement agent fees
Proceeds before offering expenses
Minimum closing bid price
Market value of listed securities closed
Aggregate payment amount
Initial cash consideration
Escrow deposit
Payable share value
Development milestone payments
Development milestone payment description
Commercialization milestone payments
Commercialization milestone payment description
Adjustment common stock and additional paid in capital
Subsequent Event [Table]
Subsequent Event [Line Items]
Net revenues
Net loss
Net change in cash
Accumulated deficit
Shares issued
Cash FDIC limit
Inventory
Escrow deposits
Number of stock options
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Related party payable
Accounts payable
Professional fees
License fee
Credit cards
Total accounts payable and accrued expenses
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Convertible debt instrument, measurement input
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Balance, beginning
Repayments
Fair value change
Balance ending
Sale of stock, consideration received on transaction
Other Prepaid Expense, Current
Debt Instrument, Face Amount
Proceeds from issuance of debt
Debt instrument original issue discount original issue discount percentage
Net proceeds
Debt Instrument, Unamortized Discount
Payments of Financing Costs
Debt Instrument, Interest Rate, Effective Percentage
Debt Instrument, Interest Rate, Stated Percentage
Debt Instrument, Maturity Date
Debt Instrument, Convertible, Conversion Price
Structuring fee
Commitment shares
Other commitment description
Sale of shares of common stock
Aggregate commitment
Fair value of convertible notes
Original discounts price
Net gain on change in fair value of convertible notes
Interest expense
Interest paid
Settlement of cash payments
Issuance of common stock
Repaid principal
Debt conversion amount
Stock Issued During Period, Shares, New Issues
Debt Instrument, Issued, Principal
Debt Instrument, Increase, Accrued Interest
Debt Conversion, Converted Instrument, Shares Issued
Interest Payable
Conversion of shares
Outstanding principal balance
FairValueOfStockOptionsTable [Table]
Dividend Yield
Weighted average expected term (years)
Volatility
Risk-free rate
Weighted average exercise price
Number of options, outstanding, beginning balance
Weighted average exercise price, outstanding, beginning balance
Weighted average contractual term (years), outstanding
Aggregate intrinsic value, outstanding, beginning balance
Number of options, granted
Weighted average exercise price, granted
Number of options, exercised
Weighted average exercise price, exercised
Number of options, forfeited
Weighted average exercise price, forfeited
Number of options, outstanding, ending balance
Weighted average exercise price, outstanding, ending balance
Aggregate intrinsic value, outstanding, ending balance
Number of options, exercisable
Weighted average exercise price, exercisable
Weighted average contractual term (years), exercisable
Aggregate intrinsic value, exercisable
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price
Number of options, outstanding
Outstanding options, weighted average remaining life
Vested options, number exercisable
Vested options, weighted average remaining life
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Preferred stock, shares issued
Preferred stock, shares outstanding
Aggregate proceeds share issuance
Share based compensation arrangement description
Director purchase, shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Description of terms of share based payment arrangement
Shares issued for services
Fair value of consideration for services
Issued of aggregate fair value shares
Number of restricted shares issued, value
Number of stock purchase
Share purchase price
Compensation expense for services
Stock option granted
Exercise price
Fair value of grant date
Vested, term
Stock options vest percentage
Option vested
Share-Based Payment Arrangement, Expense
Compensation Expense, Excluding Cost of Good and Service Sold
Salary and Wage, Officer, Excluding Cost of Good and Service Sold
Percentage of restricted stock units vested on grant date
Shares outstanding
Vested shares
Unvested shares
Unrecognized stock-based compensation
Recognized over a period
Office lease ROU
Less accumulated reduction
Balance of ROU, net
Office lease liability
Change in lease liability
Total
2026
2027
2028
2029
2030
2031
2032
Total lease payments
Less: imputed interest
Total lease liabilities
Current operating lease liabilities
Non-current operating lease liabilities
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Operating lease term
Base rent
Operating lease yearly escalation percentage
Operating lease right-of-use asset
Lease liability
Borrowing rate
Development and distribution fee
Success fee percentage
consulting expense
Annual license fee
Commitments
Royalty payments percentage
Royalty amount
Accrued license fees
Segment Reporting [Table]
Segment Reporting [Line Items]
Revenue
Selling, general and administrative
Segment net loss
Other interest income (expense), net
Number of reportable segments
Stock issued, value
Cash consideration
Stock issued, value
Front consideration
Average price per share
Pre and post split shares description
Non Rule 10b51 Arr Modified Flag.
Rule 10b51 Arr Modified Flag.
Gain on change in fair value of convertible notes.
Interest expense paid by stock.
Gain loss on amortization of prepaid contracts
Change in operating lease right of use asset and lease liabilities.
Decrease (increase) in prepaid contracts.
Increase decrease in refund liability.
Payment of convertible note from issuance of common stock.
Stock issued in connection interest payment.
Operating lease right-of-use asset obtained in exchange for operating lease liability.
Standby Equity Purchase Agreement [Member]
Minimum closing bid price
Securities Purchase Agreement [Member]
Pharm Ala Biotech Holdings Inc. [Member]
Prepaid contracts [Policy Text Block]
Clinical Trial Expenses [Policy Text Block]
Convertible Notes With Embedded Derivative Liabilities [Policy Text Block]
Titan Advisory Services LLC [Member]
Employment Agreements [Member]
YA II PN, Ltd [Member]
Original issue discount percentage.
Structuring fee
Commitment shares.
Original issue discounts.
Convertible Promissory Note [Member]
2025 Convertible Notes [Member]
SEPA [Member]
Convertible Note One [Member]
2025 Equity Incentive Plan [Member]
Entity Three [Member]
Share based compensation arrangement by share based payment award options exercisable weighted average remaining contractual term.
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Range Seven [Member]
Range Eight [Member]
Range Nine [Member]
Range Ten [Member]
Operating lease yearly escalation percentage.
Operating lease incremetal borrowing rate
Schedule of Operating Lease Assets and Liabilities [Table Text Block]
Operating lease right of use asset before accumulated amortization.
Operating lease, right-of-use asset, accumulated amortization.
Operating lease liability gross.
Change in lease liability.
Consulting Agreements [Member]
Royalty percentage.
License fee.
License Agreements [Member]
Aquanova AG [Member]
Licensing and Royalty Agreements [Member]
Debt Forgiveness and Exchange Agreement [Member]
Pharmaceutical Operations [Member]
Premium Nutritional Supplements [Member]
Segment net loss.
Notes [Member]
Percentage of restricted stock units vested on grant date.
Escrow deposits.
Reverse stock split rounding adjustment.
Stock issued during period value registered direct offering net of offering costs.
Stock issued during period shares registered direct offering net of offering costs.
Placement agent fees.
Aggregate payment amount.
Development milestone payments.
Commercialization milestone payments.
Development milestone payment description.
Commercialization milestone payment description.
Settlement of cash payments.
Convertible Promissory Note One [Member]
Two Consultants [Member]
Office Employees [Member]
Schedule of Share Based Compensation Arrangement by Share Based Payment Award Options Grants inPeriod Grant Date [Table Text Block]
Restricted stock outstanding.
consulting expense.
Consulting Agreement [Member]
Development and distribution fee.
License Agreement [Member]
Asset acquisition front consideration.
Increase decrease in escrow deposit other assets.
Other Assets [Policy Text Block]
Assets, Current
Assets [Default Label]
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Interest Expense, Nonoperating
Shares, Outstanding
GainOnChangeInFairValueOfConvertibleNotes
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Accounts Receivable
DecreaseIncreaseInPrepaidContracts
IncreaseDecreaseInEscrowDepositOtherAssets
Increase (Decrease) in Inventories
Increase (Decrease) in Other Current Assets
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Increase (Decrease) in Deferred Compensation
Increase (Decrease) in Deferred Revenue
IncreaseDecreaseinRefundLiability
Increase (Decrease) in Interest Payable, Net
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Repayments of Convertible Debt
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Cash and Cash Equivalents, Policy [Policy Text Block]
EscrowDeposits
Accounts Payable and Accrued Liabilities
Proceeds from (Repayments of) Debt
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
OperatingLeaseRightOfUseAssetAccumulatedAmortization
ChangeInLeaseLiability
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount